Imaging

The guidelines and other documents available here provide recommendations related to providing high-quality imaging services for people affected by cancer in Ontario.

Imaging Toolkit

Displaying Guidelines

72 Items

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Document Status: Current
ID: 7-20 Version 2
Version: 2

Oct 2012

Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer

Document Status: Current
ID: GL 1-14
Version: 3

Oct 2019

Breast Screening for Survivors of Breast Cancer

Document Status: Current
ID: 15-15

Sep 2017

Clinical Utility of Positron Emission Tomography in the Diagnosis, Staging and Management of Sarcoidosis

Document Status: Current
ID: PET 11

Aug 2011

Comparison of PET/CT and PET/MR Imaging in Oncology

Document Status: Current
ID: PET 16

Apr 2016

Cross-Sectional Diagnostic Imaging in Lung Cancer

Document Status: Education and Information
ID: DILung

Apr 2012

Cross-Sectional Imaging in Colorectal Cancer

Document Status: Education and Information
ID: DICRC

Sep 2012

Diagnostic Imaging in Breast Cancer

Document Status: Education and Information
ID: DIBrCa

Apr 2012

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

Document Status: Current

Jun 2014

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Document Status: Current
ID: GL END 7-14v3
Version: 3

Dec 2018

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Document Status: Current
ID: PET 2020-1
Version: N/A

Updated

Nov 2020

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2018

Document Status: Current
ID: PET 2018-2

Jul 2019